Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Eli Lilly and Co banner

Eli Lilly and Co
NYSE:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
NYSE:LLY
Watchlist
Price: 1 054.3 USD 3.28% Market Closed
Market Cap: $996.7B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

LLY Price Targets Summary
Eli Lilly and Co

Wall Street analysts forecast LLY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LLY is 1 164.09 USD with a low forecast of 713.1 USD and a high forecast of 1 575 USD.

LLY Lowest Forecast
Wall Street Target
713.1 USD
-32% Downside
LLY Average Forecast
Wall Street Target
1 164.09 USD
10% Upside
LLY Highest Forecast
Wall Street Target
1 575 USD
49% Upside
Lowest
Price Target
713.1 USD
32% Downside
Average
Price Target
1 164.09 USD
10% Upside
Highest
Price Target
1 575 USD
49% Upside
Eli Lilly and Co Competitors:
Price Targets
AMBR
Amber International Holding Ltd
332% Upside
SPH
Suburban Propane Partners LP
-11% Downside
AMBR
Amber International Holding Ltd
332% Upside
SPH
Suburban Propane Partners LP
-11% Downside

Revenue
Forecast

7% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
7% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 14 years the compound annual growth rate for Eli Lilly and Co's revenue is 7%. The projected CAGR for the next 3 years is 15%.

What are analyst estimates?

Operating Income
Forecast

12% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
12% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 14 years the compound annual growth rate for Eli Lilly and Co's operating income is 12%. The projected CAGR for the next 3 years is 17%.

What are analyst estimates?

Net Income
Forecast

12% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
12% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

For the last 14 years the compound annual growth rate for Eli Lilly and Co's net income is 12%. The projected CAGR for the next 3 years is 28%.

What are analyst estimates?

See Also

Summary
LLY intrinsic value, competitors valuation, and company profile.
DCF Valuation
LLY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LLY stock valuation using valuation multiples.
Wall Street Estimates
LLY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LLY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LLY's stock price target?
Price Target
1 164.09 USD

According to Wall Street analysts, the average 1-year price target for LLY is 1 164.09 USD with a low forecast of 713.1 USD and a high forecast of 1 575 USD.

What is Eli Lilly and Co's Revenue forecast?
Projected CAGR
15%

For the last 14 years the compound annual growth rate for Eli Lilly and Co's revenue is 7%. The projected CAGR for the next 3 years is 15%.

What is Eli Lilly and Co's Operating Income forecast?
Projected CAGR
17%

For the last 14 years the compound annual growth rate for Eli Lilly and Co's operating income is 12%. The projected CAGR for the next 3 years is 17%.

What is Eli Lilly and Co's Net Income forecast?
Projected CAGR
28%

For the last 14 years the compound annual growth rate for Eli Lilly and Co's net income is 12%. The projected CAGR for the next 3 years is 28%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 315,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.